Published in Can J Hosp Pharm on November 01, 2014
Comparison of Two Dosage Adjustment Strategies of Vancomycin in Children (OPTIBAYE) | NCT02694458
Clinical practice guidelines by the infectious diseases society of america for the treatment of methicillin-resistant Staphylococcus aureus infections in adults and children. Clin Infect Dis (2011) 11.49
High-dose vancomycin therapy for methicillin-resistant Staphylococcus aureus infections: efficacy and toxicity. Arch Intern Med (2006) 7.56
Therapeutic monitoring of vancomycin in adult patients: a consensus review of the American Society of Health-System Pharmacists, the Infectious Diseases Society of America, and the Society of Infectious Diseases Pharmacists. Am J Health Syst Pharm (2009) 7.43
The pharmacokinetic and pharmacodynamic properties of vancomycin. Clin Infect Dis (2006) 2.68
Incidence and risk factors influencing the development of vancomycin nephrotoxicity in children. J Pediatr (2011) 2.27
Systematic review and meta-analysis of vancomycin-induced nephrotoxicity associated with dosing schedules that maintain troughs between 15 and 20 milligrams per liter. Antimicrob Agents Chemother (2012) 2.15
Assessment of vancomycin dosing and subsequent serum concentrations in pediatric patients. Ann Pharmacother (2011) 1.90
Improved vancomycin dosing in children using area under the curve exposure. Pediatr Infect Dis J (2013) 1.52
Current recommended dosing of vancomycin for children with invasive methicillin-resistant Staphylococcus aureus infections is inadequate. Pediatr Infect Dis J (2009) 1.43
Pharmacokinetics and administration regimens of vancomycin in neonates, infants and children. Clin Pharmacokinet (1997) 1.35
Prediction of vancomycin pharmacodynamics in children with invasive methicillin-resistant Staphylococcus aureus infections: a Monte Carlo simulation. Clin Ther (2010) 1.15
Vancomycin dosage requirements among pediatric intensive care unit patients with normal renal function. J Crit Care (2000) 1.15
Impact of a hospitalwide increase in empiric pediatric vancomycin dosing on initial trough concentrations. Pharmacotherapy (2011) 1.09
Correlation of vancomycin dosing to serum concentrations in pediatric patients: a retrospective database review. J Pediatr Pharmacol Ther (2009) 1.09
Dosage guidelines for the use of vancomycin based on its pharmacokinetics in infants. Eur J Clin Pharmacol (1988) 1.05
Laboratory guidelines for monitoring of antimicrobial drugs. National Academy of Clinical Biochemistry. Clin Chem (1998) 1.05
An evaluation of initial vancomycin dosing in infants, children, and adolescents. Int J Pediatr (2011) 0.89
Pharmacokinetics of glycopeptide antibiotics in children. J Infect Chemother (2012) 0.85